Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Cancer Prevention Research (Philadelphia, Pa.)|January 6, 2026
Yes, It Is Worth It: Consider Participant Experiences in the Design of Future TrialsAltaf Mohammed, Goli Samimi, Kajal Biswas, et al.
Cancers|August 13, 2015
Molecular Targeted Intervention for Pancreatic CancerAltaf Mohammed, Naveena B Janakiram, Shubham Pant, et al.
Cancer Science|January 30, 2023
Genetically engineered mouse models for hereditary cancer syndromesKajal Biswas, Altaf Mohammed, Shyam K Sharan, et al.
International Journal of Molecular Sciences|August 12, 2018
Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New PerspectivesAltaf Mohammed, Nagendra Sastry Yarla, Venkateshwar Madka, et al.
Current Medicinal Chemistry|February 28, 2017
Immunoprevention of Pancreatic CancerChinthalapally V Rao, Altaf Mohammed, Adam S Asch, et al.
Molecular Nutrition & Food Research|February 3, 2016
Prevention and treatment of cancers by immune modulating nutrientsNaveena B Janakiram, Altaf Mohammed, Venkateshwar Madka, et al.
Molecular Cancer Therapeutics|January 19, 2008
Beta-ionone inhibits colonic aberrant crypt foci formation in rats, suppresses cell growth, and induces retinoid X receptor-alpha in human colon cancer cellsNaveena B Janakiram, Indranie Cooma, Altaf Mohammed, et al.
Bioorganic & Medicinal Chemistry Letters|February 11, 2014
Synthesis and in vivo evaluation of N-ethylamino-2-oxo-1,2-dihydro-quinoline-3-carboxamide for inhibition of intestinal tumorigenesis in APC(Min/+) miceGopal Pathuri, Qian Li, Altaf Mohammed, et al.
Current Medicinal Chemistry|February 11, 2017
Current Challenges and Opportunities for Chemoprevention of Pancreatic CancerAltaf Mohammed, Naveena B Janakiram, Venkateshwar Madka, et al.
Neoplasia (New York, N.Y.)|May 2, 2013
Multitargeted low-dose GLAD combination chemoprevention: a novel and promising approach to combat colon carcinogenesisAltaf Mohammed, Naveena B Janakiram, Misty Brewer, et al.
Pageof 8